EZH2 LOSS PREDISPOSES TO HETEROGENEOUS HEMATOLOGICAL MALIGNANCIES

被引:0
|
作者
Mochizuki-Kashio, M. [1 ]
Wang, C. [1 ]
Sashida, G. [1 ]
Oshima, M. [1 ]
Tomioka, T. [1 ]
Iwama, A. [1 ]
机构
[1] Chiba Univ, Cellular & Mol Med, Chiba, Japan
关键词
D O I
10.1016/S0145-2126(15)30064-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
63
引用
收藏
页码:S31 / S31
页数:1
相关论文
共 50 条
  • [1] EZH2 LOSS IN HEMATOPOIETIC STEM CELLS PREDISPOSES MICE TO DEVELOP HETEROGENEOUS MALIGNANCIES IN AN EZH1-DEPENEDENT MANNER
    Mochizuki-Kashio, Makiko
    Sashida, Goro
    Aoyama, Kazumasa
    Wang, Changshan
    Tomioka, Takahisa
    Oshima, Motohiko
    Iwama, Atsushi
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S81 - S81
  • [2] Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner
    Mochizuki-Kashio, Makiko
    Aoyama, Kazumasa
    Sashida, Goro
    Oshima, Motohiko
    Tomioka, Takahisa
    Muto, Tomoya
    Wang, Changshan
    Iwama, Atsushi
    BLOOD, 2015, 126 (10) : 1172 - 1183
  • [3] EZH2 in normal hematopoiesis and hematological malignancies
    Herviou, Laurie
    Cavalli, Giacomo
    Cartron, Guillaume
    Klein, Bernard
    Moreaux, Jerome
    ONCOTARGET, 2016, 7 (03) : 2284 - 2296
  • [4] EZH2 in Myeloid Malignancies
    Rinke, Jenny
    Chase, Andrew
    Cross, Nicholas C. P.
    Hochhaus, Andreas
    Ernst, Thomas
    CELLS, 2020, 9 (07)
  • [5] Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
    Goro Sashida
    Atsushi Iwama
    International Journal of Hematology, 2017, 105 : 23 - 30
  • [6] Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
    Sashida, Goro
    Iwama, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (01) : 23 - 30
  • [7] Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies
    Zhang, Jinwei
    Yang, Maoshuo
    Liu, Qian
    Xue, Xintong
    Tian, Sijia
    Hu, Xi
    Li, Mengzhe
    Li, Jintao
    Chai, Qipeng
    Liu, Fabao
    You, Xiaona
    Zhang, Yingjie
    BIOORGANIC CHEMISTRY, 2024, 153
  • [8] EZH2 Mutations: Mutating the Epigenetic Machinery in Myeloid Malignancies
    Abdel-Wahab, Omar
    Levine, Ross L.
    CANCER CELL, 2010, 18 (02) : 105 - 107
  • [9] Loss of EZH2 Protein Expression in Myelodysplastic Syndrome Correlates with EZH2 Mutation and Portends a Worse Outcome
    Sakhdari, Ali
    Class, Caleb
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Khoury, Joseph D.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    BLOOD, 2019, 134
  • [10] Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
    H Makishima
    A M Jankowska
    R V Tiu
    H Szpurka
    Y Sugimoto
    Z Hu
    Y Saunthararajah
    K Guinta
    M A Keddache
    P Putnam
    M A Sekeres
    A R Moliterno
    A F List
    M A McDevitt
    J P Maciejewski
    Leukemia, 2010, 24 : 1799 - 1804